Clinical Trials Logo

Congenital Myasthenic Syndrome clinical trials

View clinical trials related to Congenital Myasthenic Syndrome.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05408702 Completed - Myasthenia Gravis Clinical Trials

Exercise in Autoimmune Myasthenia Gravis and Myasthenic Syndromes

MYaEX
Start date: November 12, 2021
Phase:
Study type: Observational

A few recent observational studies show that despite the lack of clear recommendations, many individuals with myasthenia participate in exercise. However, no link has been found between exercise and the severity of myasthenia symptoms, measured by the Muscle Myasthenia Score or the Myasthenia Gravis Composite Score. This suggests that there are other factors that may limit or prevent some individuals from being active, or factors which may facilitate participation in exercise. Studies in other diseases have shown that there are internal (beliefs, motivation, etc.) and external (cost, accessibility, etc.) factors unrelated to the disease which may play a role in exercise participation. The aim of this study is to identify factors that facilitate or limit exercise in individuals with autoimmune myasthenia gravis, congenital myasthenia syndrome and Lambert-Eaton syndrome.

NCT ID: NCT01474980 Completed - Clinical trials for Congenital Myasthenic Syndrome

Pregnancy Outcomes in Congenital Myasthenie Syndrome

POCoMS
Start date: January 2010
Phase: N/A
Study type: Observational

This is a retrospective study that follows the clinical evolution, the pregnancy and the post-partum perioad of female patients with Congenital Myasthenic Syndrome.

NCT ID: NCT01203592 Completed - Clinical trials for Congenital Myasthenic Syndrome

Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes

Start date: September 2010
Phase: Phase 1
Study type: Interventional

The study tests the notion that patients suffering from certain types of congenital myasthenic syndromes are benefitted by the use of Albuterol at doses used in clinical practice.